Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CApecitabine Prior to TUmor Resection in Ent Oncology (CAPTURE)

NCT07254962 is registered in ClinicalTrials.gov with Sir Mortimer B. Davis - Jewish General Hospital as lead sponsor.

NCT NCT07254962
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07254962 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CApecitabine Prior to TUmor Resection in Ent Oncology (CAPTURE)
Lead sponsor
Sir Mortimer B. Davis - Jewish General Hospital
Phase
Phase 2
Overall status
Not yet recruiting
Start date
January 1, 2026
Completion date
January 1, 2031
Enrollment
75 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

head neck cancer, larynx cancer, mouth cancer, skin cancer face, throat cancer